genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
Authors
Posts by Alex Philippidis
Alex Philippidis
Artificial Intelligence
Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Collaboration
Bioprocessing
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence
Translational Medicine
California Still Golden Despite Job Losses: Industry Group
Genome Editing
Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets
Translational Medicine
AbbVie to Acquire Apogee Therapeutics for $10.9B
Translational Medicine
StockWatch: Positive Phase III Data Sells Investors on Intellia
Infectious Diseases
Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine
Artificial Intelligence
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
Cancer
StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO
Cancer
GSK to Acquire Nuvalent for $10.6B, Boosting Cancer Pipeline with Precision NSCLC Treatments
OMICs
10x Genomics Acquires Proteintech Genomics, Expanding Proteomics Capablities
Translational Medicine
Incyte to Acquire Vega Therapeutics for Up-to-$2B, Growing Hematology Pipeline with Phase III VWD Candidate
Translational Medicine
StockWatch: Abivax Survives a Roller Coaster Week
Infectious Diseases
A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News
Artificial Intelligence
Small Molecules to Big Partnership: Incyte, Genesis Expand AI Collaboration to $1B+
Drug Discovery
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Translational Medicine
Fulcrum Halts Development of SCD Candidate Pociredir, Sets Strategic Review
Translational Medicine
Attacking Gout: Crystalys Sees Room for Its Dotinurad and Other Allopurinol Alternatives
Drug Discovery
Top 10 U.S. Biopharma Clusters 2026
Bioprocessing
StockWatch: Agilent Shares Jump on Better than Expected Quarterly Results
<
1
2
3
4
5
6
…
167
>
Page 4 of 167
![The facility expands access to commercial drug substance and drug product release testing as well as stability testing for biopharmaceutical companies developing and commercializing therapies in Europe. [MilliporeSigma]](https://www.genengnews.com/wp-content/uploads/2026/06/Merck-KGaA-RESIZE4568-648x320.jpg "Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence")
